Sanofi to produce 100 million Pfizer/BioNTech vaccine doses, CEO says
Reuters | Paris | Updated: 26-01-2021 23:03 IST | Created: 26-01-2021 22:54 IST
French pharma giant Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, CEO Paul Hudson told Le Figaro newspaper in an interview published on Tuesday.
As Sanofi and its British partner GlaxoSmithKline have delayed the launch of their shot to late 2021, the French company decided to approach Pfizer "in order to be helpful as of now", Hudson said, adding that an agreement with the U.S. company had been reached.
Advertisement
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
ALSO READ
U.S. interested in funding flights to bring in asylum seekers -U.N. official
U.S. extends travel restrictions at land borders with Canada, Mexico through March 21
U.S. unwinds Trump 'remain in Mexico' program, mulls flights for asylum seekers
U.S. says it won't bow to pressure from Iran on more sanctions relief before potential talks
U.S. Democrat opposes Biden budget pick Tanden, risking confirmation and complicating agenda